Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Abeona Therapeutics (ABEO) Stock Forecast & Price Target

Abeona Therapeutics logo
$6.39
-0.11 (-1.69%)
(As of 10/28/2024 ET)

Abeona Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
3

Based on 3 Wall Street analysts who have issued ratings for Abeona Therapeutics in the last 12 months, the stock has a consensus rating of "Buy." Out of the 3 analysts, 3 have given a buy rating for ABEO.

Consensus Price Target

$18.00
181.69% Upside
According to the 3 analysts' twelve-month price targets for Abeona Therapeutics, the average price target is $18.00. The highest price target for ABEO is $21.00, while the lowest price target for ABEO is $15.00. The average price target represents a forecasted upside of 181.69% from the current price of $6.39.

ABEO Analyst Ratings Over Time

TypeCurrent Forecast
10/29/23 to 10/28/24
1 Month Ago
9/29/23 to 9/28/24
3 Months Ago
7/31/23 to 7/30/24
1 Year Ago
10/29/22 to 10/29/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$18.00$18.00$19.00$38.00
Forecasted Upside181.69% Upside205.60% Upside302.54% Upside924.26% Upside
Consensus Rating
Buy
Buy
Buy
Buy

ABEO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ABEO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Abeona Therapeutics Stock vs. The Competition

TypeAbeona TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.79
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside170.68% Upside17,916.81% Upside8.34% Upside
News Sentiment Rating
Very Positive News

See Recent ABEO News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/20/2024Cantor Fitzgerald
3 of 5 stars
 Reiterated RatingOverweight ➝ Overweight$18.00 ➝ $18.00+207.69%
8/14/2024HC Wainwright
2 of 5 stars
R. Selvaraju
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00+201.20%
5/30/2024Stifel Nicolaus
4 of 5 stars
 Initiated CoverageBuy$21.00+417.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:19 PM ET.


ABEO Forecast - Frequently Asked Questions

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Abeona Therapeutics is $18.00, with a high forecast of $21.00 and a low forecast of $15.00.

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Abeona Therapeutics in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ABEO shares.

According to analysts, Abeona Therapeutics's stock has a predicted upside of 181.69% based on their 12-month stock forecasts.

Abeona Therapeutics has been rated by research analysts at Cantor Fitzgerald, and HC Wainwright in the past 90 days.

Analysts like Abeona Therapeutics more than other "medical" companies. The consensus rating for Abeona Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ABEO compares to other companies.


This page (NASDAQ:ABEO) was last updated on 10/28/2024 by MarketBeat.com Staff
From Our Partners